← FDA Drug Approvals (Drugs@FDA)

METHYLERGONOVINE MALEATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2019-03-20

Drug application

FDA Application #

ANDA211455

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHYLERGONOVINE MALEATE

Generic name

METHYLERGONOVINE MALEATE

Active ingredients

METHYLERGONOVINE MALEATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Teva Pharmaceuticals USA, Inc.

First approval

2019-03-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown